ArticleAging2023

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy.

Chao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.